Barb73
-
Posts
1,549 -
Joined
-
Last visited
Content Type
Downloads
Store
Profiles
Forums
Gallery
Blogs
Events
Posts posted by Barb73
-
-
Thank you, Lily. Our greatgranddaughter arrived on the scene today, and is 5.1 lbs. and 18 inches long. She was supposed to be born early in December.
She is so sweet. Joe, her Dad, just sent us the announcement and the photo. I will tell Bill in the morning. Right now, he is off in the Land of Nod.
What a wonderful day today was. The town came by and planted two young trees on the north side (near curb). One is a fringe tree and the other, a plum.
I guess we won't be forgetting what date they were installed.
Barbara
-
Lily,
Bill and I are here with one day short of one month to go to annouance his five-year survival. Thank you, God.
It's been a ride, but very doable.
Today, our granddaughter, Nadia, is in hospital receiving induced labor (due to toxemia issues) and the good Lord Willing, they will announce that we have become GREATgrandparents of a sweet baby girl, Katelyn Marie Elizabeth.
Isn't life great?
We have spent most of the day praying for a good outcome.
Barbara and Bill
-
I cannot do the Cary Grant impression as perfectly as Kasey
, but as she did, I send you the same congrats, and am so very happy for you, Judy.Go and celebrate. That is what life is all about. Cherish each and every gift given and enjoy.
Barbara
-
http://www.fox4kc.com/lifestyle/health/ ... 2491.story
VIDEO: Click Onto
. . . . . . . . .
(Fox4kc.com, Meryl Lin McKean, Fox 4 Medical Representative, November 5, 2009)
Disclaimer:
The information contained in these articles may or may not be in agreement with my own opinions. They are not being posted with the intention of being medical advice of any kind.
-
http://www.trib.com/news/state-and-regi ... b08a6.html
ARTICLE:
. . . . . . . . .
CHEYENNE -- Wyoming Treasurer Joe Meyer announced Tuesday that he has lung cancer and expects to undergo surgery in Cheyenne next week.
Meyer, 68, said he discovered the cancer about two weeks ago when he sought medical treatment for chest pain. He said doctors have told him that the tumor in his left lung is malignant but has not spread.
Meyer, a Republican, is serving his third year as state treasurer. He also has served as Wyoming attorney general and secretary of state.
Meyer and his wife, Mary, held a news conference at the state Capitol to announce his medical condition. He said he expects to be back at work within four to six weeks. He intends to finish this term but hasn't decided whether to seek re-election next year.
The tumor is enclosed in fluid and hasn't spread to other parts of the body, Meyer said.
"All things considered, it could have been a heck of a lot worse. We're just lucky to have discovered it early," he said.
Meyer said he's been a cigarette smoker for 45 years and believes that contributed to the cancer. He said he has tried to quit many times. Meyer also said there's a history of cancer in his family.
He said the insidious thing about cigarette smoking is it takes so long for things to happen.
"It's taken 45 years," Meyer said. "You tend to minimize it in your head; you forget the lessons. I quit for two, two-and-a-half years. I felt so good. I was jogging, I was 53-54 then. But you think, 'Well heavens, I'm one of those statistics it's never going to happen to.' Well, duh. I guess it happened."
Meyer said he's confident that the staff of the treasurer's office will keep things running smoothly while he's recovering. Deputy Treasurer Sharon Garland will be in charge.
Meyer is a native of Casper and received his law degree from the University of Wyoming. He is a longtime friend of former Vice President Dick Cheney and has escorted Cheney when he has visited the Wyoming Legislature in recent years.
Posted in State-and-regional on Wednesday, November 4, 2009 12:00 am Updated: 7:18 pm. | Tags: Wyoming, News, State, Regional, Cheyenne, Treasurer, Joe Meyer
. . . . . . . . .
(Trib.com, news, State and Regional, By Ben Neary, November 4, 2009)
Disclaimer:
The information contained in these articles may or may not be in agreement with my own opinions. They are not being posted with the intention of being medical advice of any kind.
-
Shame, shame, shame, on that doctor.
I believe that his own fear is driving his simplistic answers to the prevention of cancers.
My niece has breast cancer
. Her mother (my sister) had breast cancer. Our grandmother had breast cancer.My husband has lung cancer. His grandfather died of lung cancer.
Do we think there might be a genetic factor involved here?
It's not a simple thing and that particular doctor contributes to the "stigma" of self blame that was considered anathema in the fight to get better treatments for HIV/AIDS.
ENOUGH!!!!!!
Barbara
-
http://www.pharmafocus.com/cda/focusH/1 ... 24,00.html
Article:
. . . . . . . . .
AstraZeneca withdraws filings for lung cancer drug
Monday , November 02, 2009
AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results from clinical trials of the drug.
Zactima (vandetanib) was filed for approval in June for use as a second-line therapy, in combination with chemotherapy, in patients with advanced non-small cell lung cancer.
The compound has been pitched as an important new drug candidate for AstraZeneca, which needs a new generation of products to overcome upcoming patent expiries in its portfolio on drug such as gastrointestinal Nexium (esomeprazole), Seroquel (quetiapine) for schizophrenia and cholesterol-lowerer Crestor (rosuvastatin).
Just ahead of the marketing submissions, analysts at Jefferies Research had predicted peak sales of $400 million for Zactima in NSCLC and follow-up indication thyroid cancer.
The decision to pull the dossiers is based on an updated analysis of data from the ZODIAC, ZEAL and ZEST trials, which found no overall survival advantage when Zactima 100mg was added to chemotherapy in NSCLC patients.
News of the withdrawal did not come completely out of left field, as ZEAL and ZEST did not meet their primary endpoints and AstraZeneca's decision to press ahead with filing was considered a little speculative in some quarters.
The company had been hoping to secure approval for Zactima based on the drug's effectiveness in improving progression-free survival, but based on feedback from the regulatory authorities has concluded that this will not be sufficient to underpin marketing approval.
AstraZeneca now says it will press ahead with two other phase III clinical trials of the drug - the ZEPHYR study looking at its use as a monotherapy in NSCLC and the ZETA study in advanced medullary thyroid cancer - in order to "give a more complete view of vandetanib efficacy in different clinical settings".
Results of these trials are not due until next year.
Vandetanib is designed to tackle cancer in a multitude of ways. It blocks the development of a tumour's blood supply by inhibiting vascular endothelial growth factor (VEGF), which is the same target as Roche's blockbuster cancer drug Avastin (bevacizumab).
In addition, AstraZeneca's compound restricts the growth and survival of the tumour by targeting epidermal growth factor (EGF), and directly inhibits intracellular processes, such as RET-tyrosine kinase activity, which are implicated in a number of cancers, including thyroid cancer.
. . . . . . . . .
(PharmaFocus.com, news, November 2, 2009)
Disclaimer:
The information contained in these articles may or may not be in agreement with my own opinions. They are not being posted with the intention of being medical advice of any kind.
-
http://www.baltimoresun.com/features/ba ... 0249.story
Article:
. . . . . . . . .
Rabbi Elissa Sachs-Kohen was looking for a way to join the fight against lung cancer.
The traditional fundraiser - the 5k run - was out. Sachs-Kohen hates running.
Instead, the assistant rabbi at Baltimore Hebrew Congregation and several dozen fellow yoga enthusiasts will be taking to the mats today for what they're calling the Free to Breathe Yogathon. On the first day of Lung Cancer Awareness Month, they plan to earn pledges by performing the sun salutation, a sequence of body positions in hatha yoga. One hundred and eight sun salutations, in fact, which might be more strenuous than running 3.1 miles.
Sachs-Kohen hadn't given much thought to lung cancer before her mother was diagnosed with the disease last year. Janet Kohen died 10 weeks later. She was 64.
It was during her family's ordeal that Sachs-Kohen learned that lung cancer is the nation's leading cancer killer, causing more deaths each year than breast, colon and prostate cancers combined.
She also learned that lung cancer receives less than one-twentieth of the research funding per death than those better publicized cancers get.
The National Lung Cancer Partnership blames the discrepancy on the stigma around smoking, the cause of 87 percent of lung cancer cases, and the sense that those who have developed the disease have brought it on themselves.
"Even among people who have never smoked and get this disease, if they share with somebody, 'Hey, you know, I have lung cancer,' the first question is, 'Well, did you smoke?' " says Regina Vidaver, executive director of the Madison, Wis.-based partnership. "It's such a judging question, and it's so difficult for people to bear when they're bearing a diagnosis of lung cancer."
Such judgments affect the amount of funding available for research, Vidaver says.
"It's the second-leading cause of death. It's second only to heart disease," she says. "And yet if you look at the amount of money the government spends researching the disease, it's pitiful.
"We have invested incredibly in breast cancer. We have invested incredibly in heart disease. And those investments have paid off. The survival rates are far, far higher. The mortality rates are far, far lower for those diseases because of the investments in research that we have made. We're just saying we need the same commitment to lung cancer, given the incredible toll it takes on American lives."
Events such as the Yogathon, staged by local volunteers around the country and throughout the year, but particularly during November, raise half the funds that the partnership spends each year on awareness and research, Vidaver says.
Laura Rashkin, a friend of Sachs-Kohen who has helped organize and plans to participate in the Yogathon, sees both practicality and symbolism in the choice of activity.
"There is the symbolic connection to breathing - the lungs - which is important in yoga," says the Baltimore woman, an oncology nurse at Sinai Hospital. "It's also a good type of event for people who have been affected by the disease. Anybody can do yoga."
Organizers have signed up more than 50 participants and pledges of more than $12,000 for the event today at Baltimore Hebrew Congregation. Sachs-Kohen describes her mother's death as both surprising and devastating. The Yogathon is one way she is trying to deal with it.
"It doesn't take the pain away," she says. "But it helps me to do something with it."
. . . . . . . . .
(The Baltimore Sun, Article by Matthew Hay Brown, November 1, 2009)
Disclaimer:
The information contained in these articles may or may not be in agreement with my own opinions. They are not being posted with the intention of being medical advice of any kind.
-
http://www.reuters.com/article/pressRel ... RN20091102
PRNewswire:
. . . . . . . . .
WASHINGTON, Nov. 2 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) announced today that Dr. Armando Lung Love will launch a new public service campaign aimed at creating a broader base of awareness about lung cancer.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO)
Dr. Lung Love, a versatile, multi-genre artist and ardent public health crusader, will star in "Waitin' Room Service" which is being launched today.
"I couldn't stand in the shadows anymore," said Dr. Lung Love. "I've seen too many people I know come down with lung cancer so I talked to my crew and we put this video together to help with Lung Cancer Awareness Month."
"The statistics just blew my mind," he said. "Lung cancer is a bigger killer than all those other big cancers you hear so much about put together -- and no one even talks about it."
"If any other cancer or some virus killed over 3,000 people a week there'd be a state of emergency declared. But with lung cancer, man, it's like it's all the patient's fault so why bother," Dr. Lung Love said.
"Well I'm here to say the blame game is up," he said, adding that people are not aware of who is at risk.
Two out of three new cases of lung cancer are being diagnosed now in people who never smoked or who already quit.
"Things are gonna change. Dr. Lung Love is here now," he said.
Lung cancer takes more lives each year than colon, breast and prostate cancers combined yet receives only a small fraction of their federal research funding.
The survival rates for colon, breast and prostate cancer are now 67% 89% and 99% respectively. Lung cancer's survival rate is still only 15%.
For more information on Dr. Armando Lung Love and to view the PSA, please visit www.lunglove.com.
Lung Cancer Alliance (www.lungcanceralliance.org) is the only national non-profit organization solely dedicated to patient support and advocacy for
the lung cancer community. LCA's mission is to lead the movement to reverse decades of stigma and neglect by empowering those with or at risk for the
disease, elevating awareness and changing health policy.
. . . . . . . . .
(LungCancerAlliance.org, Source: Lung Cancer Alliance, Kay Cofrancesco, November 2, 2009)
Disclaimer:
The information contained in these articles may or may not be in agreement with my own opinions. They are not being posted with the intention of being medical advice of any kind.
-
Christine,
Thanks so much for this opportunity to see Kathryn Joosten on "The View."
If it weren't for this clip, I would have missed this.
She is wonderful and so "out there" in her fight to advocate for ending the stigma that has so long plagued those struck with lung cancer.
Barbara
-
Judy,
Prayers, and more prayers for best results, and please know that you are in my thoughts.
Barbara
-
Judy,
Saying and sending up prayers for both you and your friend, Loreen (It's not easy moving from one phase to another in this journey).
Most especially in my thoughts are your scans today. Here's to very good results - prayers for that.
Barbara
-
http://nationallungcancerpartnership.or ... ymposium09
ARTICLE:
. . . . . . . . .
Lung cancer is so tightly associated with smoking in the minds of the public, patients with lung cancer can feel stigmatized by their disease regardless of whether or not they have ever smoked. Patients may feel ashamed or unjustly blamed for their illness. Such feelings may increase psychological and emotional distress, compromise patients’ ability to develop social support networks and even result in failure to seek adequate medical care and psychological support services.
To address these issues head-on, the National Lung Cancer Partnership sponsored De-stigmatizing Lung Cancer – Developing A Road Map for the Future: A Think-Tank Presentation at the World Conference on Lung Cancer. The goal of this interactive forum, moderated by Mary Ann Childers (Res Public Group), was to discuss the issues contributing to lung cancer stigma and to identify strategies to dispel this stigma.
Wayne Steward, PhD, (University of California - San Francisco) drew parallels between the causes and consequences of HIV/AIDS stigma and lung cancer stigma. Dr. Steward explained the degree of stigma associated with a disease depends on several variables: whether the patient is seen as personally responsible for the condition; whether effective treatments exist for the condition; and whether the condition or side effects are readily apparent to others. Dr. Steward also explained that widely publicized advances in HIV treatment greatly helped to combat the HIV/AIDS stigma. He predicted that once well-publicized advances in lung cancer treatment occur, the perception that lung cancer is an untreatable, incurable disease will be countered, thus reducing stigma.
Jamie Ostroff, PhD, (Memorial Sloan-Kettering Cancer Center) reviewed the growing body of scientifi c evidence documenting the stigmatization of lung cancer and the impact it has on patients. Dr. Ostroff theorized the stigmatization of lung cancer is a consequence of effective antismoking campaigns, and one way to lessen stigma is to increase understanding of nicotine addiction – to view smoking not as a character flaw, but a biological or genetic predisposition to nicotine dependence. A better understanding of the pressures that lead people to start smoking could also help reduce stigma surrounding lung cancer.
Drs. Steward and Ostroff both concluded that it is critical to develop support programs that help those affected by lung cancer manage the self-blame and shame that can accompany the disease. All lung cancer patients need to feel that they are not at fault for having the disease. They still have the right to quality health care and should be treated with respect.
In a roundtable discussion, speakers and meeting participants stressed the need to unite lung cancer patients regardless of cause of their illness, to empower them with a voice for advocacy and to combat the perception of lung cancer as a self-inflicted death sentence.
. . . . . . . . .
(LungCancerPartnership.org, Article on Stigma Symposium, Podcasts, Fall 2009 Issue)
Disclaimer:
The information contained in these articles may or may not be in agreement with my own opinions. They are not being posted with the intention of being medical advice of any kind.
-
http://www.prnewswire.com/news-releases ... 77357.html
ARTILCE:
. . . . . . . . .
WASHINGTON, Oct. 30 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) praised Congressman Mike Thompson (D-CA) for his endorsement of the Lung Cancer Mortality Reduction Act of 2009. Thompson joins Representatives Michael Honda (D-CA), Barbara Lee (D-CA) and Lucille Roybal-Allard (D-CA) in strengthening California's Congressional support for this critically needed legislation.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO)
The Senate version of the Lung Cancer Mortality Reduction Act of 2009 was first introduced in the Senate by California Senator Dianne Feinstein (D-CA) and Senator Sam Brownback (R-KS) with Senator Barbara Boxer (D-CA) as an original co-sponsor.
"Lung cancer affects millions of men and women everyday and we must do everything we can to combat this deadly disease" said Thompson. "This legislation sets up a comprehensive program intended to drive lung cancer research forward and find innovative new methods of diagnosis and treatment."
Lung cancer is the leading cause of cancer death both nationally and in California. This year alone it will take the lives of more Californians than breast, prostate and colon cancers -- combined.
"This bill addresses the critical need for increased research funding for the most stigmatized and ignored cancer, lung cancer," said LCA-California Co-chair, Gloria Hovde. "We applaud Congressman Thompson for recognizing the importance of this legislation making lung cancer a national public health priority."
Introduced in the House by Representatives Donna Christensen (D-VI) and Frank LoBiondo (R-NJ), the Lung Cancer Mortality Reduction Act of 2009 is the first ever federal legislation requiring the Secretaries of Health and Human Services, Defense and Veterans Affairs to combine forces on a comprehensive, coordinated plan of action to reduce lung cancer mortality by 50% by 2015.
In addition, LCMRA directs the Secretaries of Department of Defense (DOD) and Veterans' Affairs (VA) to implement an early detection and disease management program for military personnel who are at high risk for lung cancer because of smoking or exposure to carcinogens during active duty.
The legislation also:
Authorizes the Food and Drug Administration (FDA) to create a new Lung Cancer Mortality Reduction drug program with incentives for new treatments, targeted therapies, vaccines and chemoprevention drugs for precancerous conditions.
Requires the Centers for Disease Control and Prevention to carry out an early disease research program targeted at the high incidence and mortality rates among minority and low-income populations.
Includes specific authorizations of $75,000,000 for certain NIH agencies in FY10 and authorizes such additional sums as may be necessary for all the cited agencies to accomplish the goal for FY 2010 through FY2014.
Lung Cancer Alliance (www.lungcanceralliance.org) is the only national non-profit organization solely dedicated to patient support and advocacy for the lung cancer community. LCA's mission is to lead the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.
CONTACT:Gloria Hovde of Lung Cancer Alliance, +1-707-995-0149, ghovde@lungcanceralliance.org
. . . . . . . . .
(prnewswire.com, News Release, Source: Lung Cancer Alliance, October 31, 2009)
Disclaimer:
The information contained in these articles may or may not be in agreement with my own opinions. They are not being posted with the intention of being medical advice of any kind.
-
Lily,
That was beautiful and touching. Thank you.
Barbara
-
Denise,
You're analysis of "enlarged and hardened" gave me such a good out-loud laugh.
Thanks.
With your strength and good humor, you are already a winner - no doubt about it.
Barbara
-
-
Denise,
Seems you cannot catch a break from stress. But, with everyone sending up prayers, Denise, I am sure you will find some solutions.
You are on my prayer list as you have been.
Sending you best vibes. Hang in there,
Barbara
-
I am so glad that you have found us, but of course, not glad for the reason.
You have come to a wonderful place to gather information and support.
When my husband was diagnosed with Stage 3B over four plus years ago, it was inoperable. Within that first year, he developed a metastasis to the neck and a short bit later, to the shoulder, and well over two years ago, completed whole brain radiation for a metastasis to the mid-brain.
He has had many chemotherapies, radiation and has come through all of them to land where we are now all this time after diagnosis.
Even with the many regimens, he has come through with flying colors. The most he has ever suffered was a certain fatigue that can be a side effect. The meds they have today for nausea and the like, can be very effective.
Has it been a roller coaster ride of feelings? Oh yeah, but on the good side, my husband and I have enjoyed almost five years of living with lung cancer.
We are now awaiting the birth of our first great granddaughter around Thanksgiving.
Barbara
-
http://lungcancer.about.com/b/2009/10/2 ... cancer.htm
ARTICLE:
. . . . . . . . .
I'm not always in the right place at the right time. Though I love doing anything to raise awareness and support those touched by lung cancer - I can't always get there. (And I think I wore out my excuse at home that I have to build up my frequent flyer miles...) No problem. I can walk anywhere on November 7th.
The Free to Breathe ® National Run/Walk for lung cancer will be held on November 7th 2009. No matter where you live, if shortness of breath limits your activity, or if you just prefer to march (or walk or run) to your own drummer, you can join others around the country to raise awareness about lung cancer.
At this time in October, I think most of us are aware of breast cancer. But lung cancer kills more women each year than breast cancer, ovarian cancer, and uterine cancer, combined. Ladies -- It is time we start walking, running, paddling, scrapbooking, climbing, or whatever it takes to raise awareness about lung cancer as well!
Still, nothing can beat the camaraderie of gathering with other lung cancer survivors, families, friends, and advocates to raise awareness. Check out Free to Breathe ® to see if there is an upcoming walk or yogathon (yes, performing the Sun Salutations to support those who have been touched by lung cancer), in your town.
If you still have energy left after your walk, or are not in a knot from those yoga stances, the National Lung Cancer Partnership has some more great ideas we can use anywhere, anytime, to help raise awareness and support for our loved ones living with lung cancer. Time to run - I sense a brainstorm forming...
. . . . . . . . .
(About.com, Lung Cancer Blog, Lynne Eldridge, October 26, 2009)
Disclaimer:
The information contained in these articles may or may not be in agreement with my own opinions. They are not being posted with the intention of being medical advice of any kind.
-
Patti,
So glad this thread came up again.
It seems I am always late to the party, and this is especially one I didn't want to miss.Congratulations on the three years, and on having (not surprisingly) a wonderful son. You are an inspiration, a loving mother, an avid supporter, and a fantastic lung cancer survivor. There are many more kudos I could give, but you already "get" how I feel.
You have proven that stats DO NOT tell the story.
.....and they never will.
Barbara
-
Dear Tami,
May I add my prayers for a successful outcome.
Barbara
-
http://uscnews.usc.edu/health/newton_ta ... earch.html
ARTICLE:
. . . . . . . . .
Paul K. Newton, a USC specialist in applied mathematics, will participate in a new physics oncology center, working with scientists at the Scripps Research Institute and other institutions.
The National Cancer Institute of the National Institutes of Health today announced a five-year grant to create the Physical Science-Oncology Center based at USC.
Andrew J. Viterbi, a National Medal of Science winner, a pioneer in digital communications and the namesake of the USC Viterbi School of Engineering, will be an adviser to the center.
Research at the center, which will be led by Scripps Research, will aim to achieve a better understanding of the behavior of cancer cells during metastasis - the spread of cancer from a primary tumor to other sites throughout the body. This understanding is directly aimed at determining more effective methods to manage cancer.
Newton has appointments in USC Viterbi’s Department of Aerospace and Mechanical Engineering and the USC College Department of Mathematics. He specializes in using tools and concepts from nonlinear dynamical systems theory applied to fluid dynamics and other problems in mechanics.
His concept of embedded dynamical systems will be used in the modeling and simulation of individual and swarms of metastasizing cancer cells as they circulate through the human vascular system.
“We are excited by the award,” said Scripps Research professor Peter Kuhn, the principal investigator of the grant. “We hope that by uniting an outstanding translational team of scientists and clinicians in different specialties, we can make rapid headway in filling in the large gaps in our knowledge about the behavior of cancer cells that circulate in the bloodstream. We hope this information will ultimately help clinicians determine who should be receiving aggressive treatments and who should not, as well as laying the groundwork for the development of novel therapeutic approaches.”
The grant was awarded under the first round of funding from a new signature initiative of the National Cancer Institute. The initiative, conceptualized last year in a series of think tank meetings in Washington, D.C., creates a series of 12 Physical Sciences-Oncology Centers whose aim is to advance the understanding of the physical laws and principles that shape and govern the emergence and behavior of cancer.
The Scripps Research-led consortium is dubbed the “4DB Center” after the project’s full name, “Focusing on Four-Dimensional Heterogeneity of Fluid Phase Biopsies in Cancer.” The project brings together oncologists and pathologists at the Scripps Clinic, the Moores Cancer Center at the University of California, San Diego, and Billings Clinic (Montana) with physicists and biologists the at Scripps Research Institute and biomedical engineers at Oregon Health and Sciences University, in addition to USC.
Together, the team hopes to generate a comprehensive portrait of cancer cells, including their numbers, physical properties and gene expression profiles, as they act through space (in the patients’ body), as well as time, over the course of the disease’s progression.
The researchers will track two types of cancer cells: those from patients with colon cancer, which characteristically shows a slow clinical course, and those from patients with non-small cell lung cancer, which typically shows a more aggressive and rapid clinical course with greater differences in disease progression among individuals.
This will be the first time that such a study has been conducted. Until recently, the technology was not available to make these types of observations about cancer cells without frequent biopsies from patients.
Advances in the field, however, now make it possible to analyze information from circulating tumor cells from simple blood samples collected from patients. Newton will lead the 4DB effort in physical and predictive modeling with his group of graduate students and postdoctoral researchers based at USC Viterbi.
“Working directly with blood samples from cancer patients provides a direct link to the bedside,” Kuhn said. “There is a rather long and depressing list of anti-cancer therapeutics that were tremendously successful in animal models, but that failed to exhibit activity against cancer when tested in humans. Our ability to work with human blood samples should increase the relevance of our findings to those in need.”
. . . . . . . . .
(University of Southern California Education/Health News, Article by Eric Mankin, October 27, 2009)
Disclaimer:
The information contained in these articles may or may not be in agreement with my own opinions. They are not being posted with the intention of being medical advice of any kind.
-
Well, I guess I'll add Bill's 4 years, 10 + months to the mix. He has earned them by taking on lung cancer as a job. This he has done with dignity, and given his all since December 4, 2004.
He is on hospice (voluntarily) due to the issue of no more treatments available in the pipeline.
(Most clinical trials not available due to having had so many regimens). The hospice is taking up the pain problem (they are helping a lot with that shoulder). For now, we are still giving it our best.
He still gets up and is active every day. Mainly, he is still alive and kickin'.
What is important, I think, is that survivor is a word in spirit, as well. May everyone here enjoy survivorship in every way possible.
Bill is living proof that God is the only One to call the shots, thankfully.
God bless everyone here with bountiful survivorship.
Barbara
, but as she did, I send you the same congrats, and am so very happy for you, Judy.
. Her mother (my sister) had breast cancer. Our grandmother had breast cancer.
It seems I am always late to the party, and this is especially one I didn't want to miss.
Roll Call
in HOPE
Posted
Just a short note to say that in all the excitement, I forgot to say that Mother and Baby are doing very well.
Bill is so glad he has survived to see this day. It's been very blessed. I showed him the beautiful photo of KayMarie.
Keeping hope alive - always,
Barbara